HHS Secretary Kennedy adopts CDC advisors' chikungunya vaccine guidance for Bavarian Nordic's shot, while RSV vaccine ...

Calley Means, advisor to RFK Jr., challenges drugmakers considering pulling investment in the US over Trump's most favored ...

The comments come just a couple months after the company slashed its 2027 sales expectations for the Biogen-partnered ...

Bristol Myers Squibb CEO Chris Boerner said America’s role as the global biopharma leader is at a 'pivot point' as the Trump ...

Vinay Prasad may have just started as the new director of the FDA's biologics center, but he's 'planning to unleash a massive ...

The FDA’s drug promotion office is calling out Australia's Mayne Pharma for making “false or misleading claims” about the ...

AGC Bio partners with Quell for vectors; Thermo Fisher makes Cybin's CYB003; PeptiSystems teams with Asahi Kasei; TriLink & ...

Seventeen health systems have signed up for a venture firm to help them vet which health tech companies to adopt and invest ...

Merck KGaA keeps US tariff surcharge while pausing China fees; cuts sales guidance to €20.9-22.4B amid economic uncertainty.

HHS Secretary Robert F. Kennedy Jr. faced hours of congressional grilling on Wednesday over his proposed budget cuts and ...

GSK to pay $1.2B upfront to Boston Pharmaceuticals for efimosfermin alfa, a MASH drug candidate. Deal includes $800M in ...

AbbVie partners with ADARx Pharmaceuticals in $335M upfront deal for siRNA tech collaboration across neuroscience, immunology ...